ScholarIQanswers from OpenAlex

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

PaperCitations, authors & open-access status

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure have?

ScholarIQcitation count

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure has 648 citations in the OpenAlex counts ScholarIQ stores.

When was Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure published?

ScholarIQyear

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure has 2020 year in the ScholarIQ index.

What is the open-access status of Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure?

ScholarIQoa status

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure has bronze oa status in the ScholarIQ index.

What is the DOI of Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure?

ScholarIQdoi

The DOI for Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure is on the source record.

What is the PMID of Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure?

ScholarIQpmid

The PMID for Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure is on the source record.

What is the OpenAlex record for Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure?

ScholarIQopenalex

The OpenAlex for Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial